Stock listing

LSE:0G99 Oxurion NV Share Price

UK listing (LSE) of Oxurion NV · home listing Euronext:OXUR

Follow Oxurion NV into a list and get an email when it puts out news.

Home listing price · EURONEXT:OXUR

€0.0010 EUR +0.0002 (+25.0%)

Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:OXUR

Past 3 months -64.3% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits

Day range: €0.0010 – €0.0010 EUROct 19, 2026
Volume: 146,690 sharesOct 19, 2026
Market cap: €176,449 EURAt the close on Oct 19, 2026 · price × 176.4M shares outstanding

Prices by listing

Listing	Last	Change	Volume	Open	High	Low	Previous close	Price from
Euronext:OXUR · Home	€0.0010 EUR	+0.0002 (+25.0%)	146,690	€0.0010	€0.0010	€0.0010	€0.0008	Close on Oct 19, 2026
Frankfurt:TG40	€0.0002 EUR	0.0000 (0.0%)	—	€0.0002	€0.0002	€0.0002	€0.0002	Close on Oct 19, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 19, 2026 · EURONEXT:OXUR · EUR, adjusted for splits

Day	Close	Change	%	Open	High	Low	Volume
Mon, Oct 19	€0.0010	+0.0002	+25.0%	€0.0010	€0.0010	€0.0010	146,690
Fri, Oct 16	€0.0008	0.0000	0.0%	€0.0010	€0.0010	€0.0008	115,001
Thu, Oct 15	€0.0008	0.0000	0.0%	€0.0010	€0.0010	€0.0008	260,234
Wed, Oct 14	€0.0008	-0.0002	-20.0%	€0.0010	€0.0010	€0.0008	303,996
Tue, Oct 13	€0.0010	0.0000	0.0%	€0.0010	€0.0010	€0.0008	183,000
Mon, Oct 12	€0.0010	-0.0002	-16.7%	€0.0012	€0.0012	€0.0008	735,950
Fri, Oct 9	€0.0012	0.0000	0.0%	€0.0012	€0.0012	€0.0008	1,631,383
Thu, Oct 8	€0.0012	0.0000	0.0%	€0.0012	€0.0012	€0.0010	517,029
Wed, Oct 7	€0.0012	+0.0002	+20.0%	€0.0012	€0.0012	€0.0010	1,275,586
Tue, Oct 6	€0.0010	0.0000	0.0%	€0.0012	€0.0012	€0.0010	9,731,721
Mon, Oct 5	€0.0010	-0.0006	-37.5%	€0.0012	€0.0012	€0.0010	21,836,869
Fri, Oct 2	€0.0016	0.0000	0.0%	€0.0012	€0.0016	€0.0012	136,344
Thu, Oct 1	€0.0016	+0.0002	+14.3%	€0.0012	€0.0016	€0.0012	1,440,276
Wed, Sep 30	€0.0014	+0.0002	+16.7%	€0.0012	€0.0016	€0.0012	742,283
Tue, Sep 29	€0.0012	-0.0006	-33.3%	€0.0016	€0.0018	€0.0012	6,322,878
Mon, Sep 28	€0.0018	0.0000	0.0%	€0.0018	€0.0018	€0.0014	159,399
Fri, Sep 25	€0.0018	0.0000	0.0%	€0.0016	€0.0018	€0.0014	2,757,034
Thu, Sep 24	€0.0018	+0.0002	+12.5%	€0.0020	€0.0020	€0.0016	2,279,496
Wed, Sep 23	€0.0016	-0.0002	-11.1%	€0.0022	€0.0022	€0.0016	3,216,867
Tue, Sep 22	€0.0018	0.0000	0.0%	€0.0020	€0.0026	€0.0018	7,819,121
Mon, Sep 21	€0.0018	-0.0004	-18.2%	€0.0028	€0.0028	€0.0018	5,376,678
Fri, Sep 18	€0.0022	-0.0006	-21.4%	€0.0026	€0.0026	€0.0020	3,384,344
Thu, Sep 17	€0.0028	0.0000	0.0%	€0.0028	€0.0028	€0.0024	245,800
Wed, Sep 16	€0.0028	+0.0004	+16.7%	€0.0026	€0.0028	€0.0026	41,666
Tue, Sep 15	€0.0024	-0.0002	-7.7%	€0.0026	€0.0026	€0.0024	2,200
Mon, Sep 14	€0.0026	0.0000	0.0%	€0.0024	€0.0026	€0.0024	112,829
Fri, Sep 11	€0.0026	+0.0002	+8.3%	€0.0024	€0.0026	€0.0024	13,302
Thu, Sep 10	€0.0024	-0.0002	-7.7%	€0.0026	€0.0026	€0.0024	117,970
Wed, Sep 9	€0.0026	-0.0002	-7.1%	€0.0024	€0.0026	€0.0024	1,158,950
Tue, Sep 8	€0.0028	0.0000	0.0%	€0.0028	€0.0028	€0.0024	3,185,125
Mon, Sep 7	€0.0028	+0.0002	+7.7%	€0.0026	€0.0028	€0.0026	67,002
Fri, Sep 4	€0.0026	0.0000	0.0%	€0.0028	€0.0028	€0.0026	1,640
Thu, Sep 3	€0.0026	0.0000	0.0%	€0.0026	€0.0028	€0.0026	360,234
Wed, Sep 2	€0.0026	0.0000	0.0%	€0.0026	€0.0026	€0.0026	158,176
Tue, Sep 1	€0.0026	0.0000	0.0%	€0.0030	€0.0030	€0.0026	292,570
Mon, Aug 31	€0.0026	0.0000	0.0%	€0.0026	€0.0028	€0.0026	124,644
Fri, Aug 28	€0.0026	-0.0002	-7.1%	€0.0028	€0.0028	€0.0026	1,133,367
Thu, Aug 27	€0.0028	-0.0002	-6.7%	€0.0032	€0.0032	€0.0026	381,834
Wed, Aug 26	€0.0030	+0.0004	+15.4%	€0.0026	€0.0036	€0.0026	4,631,424
Tue, Aug 25	€0.0026	0.0000	0.0%	€0.0026	€0.0028	€0.0026	111,270
Mon, Aug 24	€0.0026	-0.0002	-7.1%	€0.0024	€0.0028	€0.0024	281,105
Fri, Aug 21	€0.0028	0.0000	0.0%	€0.0028	€0.0028	€0.0028	46,500
Thu, Aug 20	€0.0028	0.0000	0.0%	€0.0028	€0.0028	€0.0028	100,000
Wed, Aug 19	€0.0028	0.0000	0.0%	€0.0028	€0.0028	€0.0028	140,414
Tue, Aug 18	€0.0028	+0.0004	+16.7%	€0.0024	€0.0028	€0.0024	408,600
Mon, Aug 17	€0.0024	-0.0002	-7.7%	€0.0026	€0.0028	€0.0024	250,855
Fri, Aug 14	€0.0026	-0.0002	-7.1%	€0.0028	€0.0028	€0.0026	477,627
Thu, Aug 13	€0.0028	+0.0002	+7.7%	€0.0028	€0.0028	€0.0026	227,781
Wed, Aug 12	€0.0026	0.0000	0.0%	€0.0028	€0.0028	€0.0026	15,602
Tue, Aug 11	€0.0026	-0.0002	-7.1%	€0.0026	€0.0028	€0.0026	96,946
Mon, Aug 10	€0.0028	0.0000	0.0%	€0.0028	€0.0028	€0.0028	60,142
Fri, Aug 7	€0.0028	+0.0002	+7.7%	€0.0026	€0.0028	€0.0026	561,758
Thu, Aug 6	€0.0026	0.0000	0.0%	€0.0028	€0.0028	€0.0026	49,503
Wed, Aug 5	€0.0026	0.0000	0.0%	€0.0024	€0.0028	€0.0024	566,110
Tue, Aug 4	€0.0026	+0.0002	+8.3%	€0.0028	€0.0028	€0.0026	452,827
Mon, Aug 3	€0.0024	0.0000	0.0%	€0.0026	€0.0028	€0.0024	805,523
Fri, Jul 31	€0.0024	-0.0004	-14.3%	€0.0028	€0.0028	€0.0024	192,000
Thu, Jul 30	€0.0028	+0.0002	+7.7%	€0.0028	€0.0028	€0.0026	115,428
Wed, Jul 29	€0.0026	0.0000	0.0%	€0.0028	€0.0028	€0.0024	118,172
Tue, Jul 28	€0.0026	0.0000	0.0%	€0.0026	€0.0026	€0.0026	6,073
Mon, Jul 27	€0.0026	0.0000	0.0%	€0.0026	€0.0026	€0.0026	219,330
Fri, Jul 24	€0.0026	+0.0002	+8.3%	€0.0024	€0.0026	€0.0022	519,622
Thu, Jul 23	€0.0024	+0.0002	+9.1%	€0.0022	€0.0024	€0.0022	217,870
Wed, Jul 22	€0.0022	-0.0002	-8.3%	€0.0024	€0.0024	€0.0022	260,002
Tue, Jul 21	€0.0024	-0.0002	-7.7%	€0.0028	€0.0028	€0.0020	3,610,342
Mon, Jul 20	€0.0026	-0.0002	-7.1%	€0.0028	€0.0028	€0.0026	66,309

Ticker: LSE:0G99
Asset type: Stock
Sector: Health care
Industry: Diagnostics & research services
Exchange: LSE
Currency: EUR

What changed lately

Latest news release · Sep 30, 2026
Interim Financial Report — Half-year results as of 30 June 2026 (EN)

Latest news

Interim Financial Report — Half-year results as of 30 June 2026 (EN)

Sep 30, 2026

Closed €0.0016 (+14.3%) on Oct 1, 2026

Oxurion: Oxurion Publishes First Half 2026 Results

Sep 30, 2026

Closed €0.0016 (+14.3%) on Oct 1, 2026

Oxurion: Oxurion enters into exclusive negotiations to acquire the business and assets of Eclevar, a MedTech-focused CRO

Sep 30, 2026

Closed €0.0014 (+16.7%) on Sep 30, 2026

Oxurion: Oxurion expands its clinical research platform through strategic biometrics partnership between Axiodis CRO and KYomed INNOV

Jul 21, 2026

Closed €0.0024 (-7.7%) on Jul 21, 2026

Oxurion: Oxurion achieves another milestone in the expansion of the Exagis platform with the commercial launch of its eTMF module

Jul 6, 2026

Closed €0.0028 (0.0%) on Jul 7, 2026

Oxurion: Oxurion launches a software-driven growth strategy with Exagis

Jun 8, 2026

Oxurion: Oxurion Announces Results on the Annual Shareholders’ Meeting of 1 June 2026

Jun 3, 2026

Oxurion: Oxurion expands its capabilities to address the growing demand for GLP-1 and peptide clinical research services

Jun 2, 2026

Oxurion - Termination of discussions for the French CRO project (LOI dated 13/10/25) and prioritization of the international target (LOI dated 19/03/26)

Jun 2, 2026

Publication Annual Report - Annual Shareholders Meeting

Apr 30, 2026

All Oxurion NV news

Decks

Technical Presentation (June 2022)
Technical · 12 slides · Jun 7, 2022
Investor Presentation (May 2022)
Investor deck · 21 slides · May 2022
Investor Presentation (February 2022)
Investor deck · 45 slides · February 2022
Investor Presentation (January 2022)
Investor deck · 32 slides · January 2022

Oxurion NV on 6ix

Sector: Health care
Industry: Diagnostics & research services
News releases: 15 in the last 12 months · 15 in all · newest Sep 30, 2026 · oldest 2025
Decks: 9 decks · latest Jun 7, 2022

Where Oxurion NV is listed

Listing	Exchange	Country	Currency
Euronext:OXUR · Home listing	Euronext	Belgium	EUR
LSE:0G99 · This page	LSE	United Kingdom	EUR
LS Exchange:A40H8H	LS Exchange	Germany	EUR
gettex:TG40	gettex	Germany	EUR
Lang & Schwarz:A40H8H	Lang & Schwarz	Germany	EUR
Frankfurt:TG40	Frankfurt	Germany	EUR
Stuttgart:TG40	Stuttgart	Germany	EUR
Aquis:OXURB	Aquis	United Kingdom	EUR
Aquis:OXURB	Aquis	United Kingdom	EUR
Turquoise:OXURB	Turquoise	United Kingdom	EUR

LSE:0G99 Oxurion NV Share Price

Prices by listing

Daily closes

What changed lately

Interim Financial Report — Half-year results as of 30 June 2026 (EN)

Latest news

Interim Financial Report — Half-year results as of 30 June 2026 (EN)

Oxurion: Oxurion Publishes First Half 2026 Results

Oxurion: Oxurion enters into exclusive negotiations to acquire the business and assets of Eclevar, a MedTech-focused CRO

Oxurion: Oxurion expands its clinical research platform through strategic biometrics partnership between Axiodis CRO and KYomed INNOV

Oxurion: Oxurion achieves another milestone in the expansion of the Exagis platform with the commercial launch of its eTMF module

Oxurion: Oxurion launches a software-driven growth strategy with Exagis

Oxurion: Oxurion Announces Results on the Annual Shareholders’ Meeting of 1 June 2026

Oxurion: Oxurion expands its capabilities to address the growing demand for GLP-1 and peptide clinical research services

Oxurion - Termination of discussions for the French CRO project (LOI dated 13/10/25) and prioritization of the international target (LOI dated 19/03/26)

Publication Annual Report - Annual Shareholders Meeting

Decks

Technical Presentation (June 2022)

Investor Presentation (May 2022)

Investor Presentation (February 2022)

Investor Presentation (January 2022)

Oxurion NV on 6ix

Where Oxurion NV is listed